---
title: "SYRE: Q3 2027 UC combination data will set Phase III priorities; HS data follow"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/305691133.md"
description: "SKYLINE's more-than-600-patient UC combination study is expected to read out in Q3 2027 and guide Phase III choices. HS combination proof-of-concept data are expected in late 2027 or early 2028.Based on DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source."
datetime: "2026-11-16T14:52:17.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/305691133.md)
  - [en](https://longbridge.com/en/news/305691133.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/305691133.md)
generator: "portal-rs"
---

# SYRE: Q3 2027 UC combination data will set Phase III priorities; HS data follow

SKYLINE's more-than-600-patient UC combination study is expected to read out in Q3 2027 and guide Phase III choices. HS combination proof-of-concept data are expected in late 2027 or early 2028.

Based on 

**Disclaimer**

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

### Related Stocks

- [CRMN.US](https://longbridge.com/en/quote/CRMN.US.md)
- [KAZR.US](https://longbridge.com/en/quote/KAZR.US.md)

## Related News & Research

- [Skyline Builders signs term sheet to acquire SuperCritical Materials](https://longbridge.com/en/news/305323282.md)
- [Skyline Builders Changes Nasdaq Ticker to CRMN From KAZR](https://longbridge.com/en/news/305317165.md)
- [Skyline Builders Group Holding Signs Term Sheet For A Business Combination With Super Critical Materials](https://longbridge.com/en/news/305332390.md)
- [Cove Kaz Capital Group Announces Termination Of Business Combination Agreement With Skyline Builders Group Holding Limited](https://longbridge.com/en/news/303969257.md)
- [Skyline Builders delays annual report filing after financial statement completion setback](https://longbridge.com/en/news/294496103.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**